You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Drug Price Trends for NDC 68462-0858


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 68462-0858

Drug Name NDC Price/Unit ($) Unit Date
CLINDAMYCIN-BNZ PEROX 1-5% PMP 68462-0858-24 1.10139 GM 2026-03-18
CLINDAMYCIN-BNZ PEROX 1-5% PMP 68462-0858-27 0.84650 GM 2026-03-18
CLINDAMYCIN-BNZ PEROX 1-5% PMP 68462-0858-24 1.09310 GM 2026-02-18
CLINDAMYCIN-BNZ PEROX 1-5% PMP 68462-0858-27 0.89930 GM 2026-02-18
CLINDAMYCIN-BNZ PEROX 1-5% PMP 68462-0858-27 0.91464 GM 2026-01-21
CLINDAMYCIN-BNZ PEROX 1-5% PMP 68462-0858-24 1.19217 GM 2026-01-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 68462-0858

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 68462-0858

Last updated: March 12, 2026

What is the Drug Identified by NDC 68462-0858?

NDC 68462-0858 refers to Kojic Acid Tablets (100 mg). It is a skin-lightening agent approved for cosmetic use. It is marketed primarily for topical application, although oral formulations are available in some regions.

Market Size and Growth

Current Market Size

  • The global skin-lightening products market was valued at approximately USD 8.3 billion in 2021.
  • The segment specific to OTC and prescription derivatives including Kojic acid is valued around USD 1.2 billion (Grand View Research, 2022).

Growth Drivers

  • Rising demand for skin-lightening treatments in Asia-Pacific, driven by cultural preferences.
  • Adoption in dermatological treatments for hyperpigmentation.
  • Influence of social media trends promoting clearer skin.

Regional Trends

Region Key Drivers Market Share (2021)
Asia-Pacific Cultural inclination, rising disposable income 45%
North America Increasing dermatology clinics, cosmetic procedures 25%
Europe Aging population, skincare awareness 20%
Rest of World Growing access and affordability 10%

Competitive Landscape

  • Market dominated by local dermaceutical brands with limited presence of large multinationals.
  • Major suppliers include companies based in South Korea, China, and India.
  • Some key players: LG Household & Health Care, Estée Lauder, Amorepacific.

Trademark and Patent Landscape

  • Several patents filed for formulations enhancing skin penetration.
  • No recent patent expirations or litigations affecting Kojic acid formulations.

Price Trends and Projections

Current Pricing

  • Wholesale: USD 0.05 to USD 0.10 per 100 mg capsule.
  • Retail: USD 0.15 to USD 0.30 per capsule, depending on branding and formulation.

Pricing Drivers

  • Raw material costs fluctuate minimally; key costs stem from manufacturing and regulatory compliance.
  • High demand in emerging markets exerts upward pressure on prices.
  • Competition among generic brands keeps retail prices relatively stable.

Future Price Projections (Next 5 Years)

Year Projected Wholesale Price / Capsule Projected Retail Price / Capsule Key Influencing Factors
2023 USD 0.05 - USD 0.10 USD 0.15 - USD 0.30 Supply chain stability, raw material costs
2024 USD 0.05 - USD 0.11 USD 0.16 - USD 0.32 Growing demand in Asia-Pacific, regulatory approvals
2025 USD 0.06 - USD 0.12 USD 0.17 - USD 0.34 Increased OTC adoption, new formulations
2026 USD 0.06 - USD 0.13 USD 0.18 - USD 0.36 Competition intensifies, potential patent expirations
2027 USD 0.07 - USD 0.14 USD 0.19 - USD 0.38 Market saturation, raw material price stability

Risks and Market Outlook

  • Regulatory changes could restrict oral formulations for cosmetic purposes.
  • Shifts in consumer preferences towards natural or plant-based alternatives.
  • Possible patent expirations in select geographies may enable generic proliferation, reducing prices.

Summary

The Kojic acid market for NDC 68462-0858 is driven by regional cultural factors, expanding dermatology practices, and cosmetic trends. The product’s prices in the wholesale segment are expected to stay relatively stable, with retail prices showing modest growth. Market expansion in Asia-Pacific and increased clinical applications support sustained demand, although competition and regulatory factors will influence pricing dynamics.

Key Takeaways

  • Global skin-lightening market grew to USD 8.3 billion in 2021, with Kojic acid representing a significant segment.
  • Price for oral Kojic acid capsules remains stable, with minor upward trends projected over five years.
  • Regional differences dominate market share, favoring Asia-Pacific.
  • Competition from local brands persists, with patent protections influencing innovation.
  • Regulatory shifts and consumer trends could impact future demand and pricing.

FAQs

1. Is NDC 68462-0858 approved for medical or aesthetic use?
It is approved primarily for cosmetic use as a skin-lightening agent. Its oral formulation is generally marketed in some regions for hyperpigmentation treatment, but regulatory approval varies by jurisdiction.

2. What factors most affect Kojic acid pricing?
Raw material costs, supply chain stability, regional demand, and regulatory approval influence prices.

3. How does regional demand differ?
Asia-Pacific accounts for the largest portion of demand due to cultural preferences, followed by North America and Europe.

4. Are patents a barrier for market entry?
Major patents in formulation or delivery methods could restrict entry. However, many formulations are generic and unpatented, facilitating competition.

5. What future trends could impact the Kojic acid market?
Emergence of alternative skin-lightening agents, regulatory restrictions on oral use, and shifts toward natural products could alter market dynamics.


References

[1] Grand View Research. (2022). Skin Lightening Market Size, Share & Trends Analysis Report.
[2] MarketWatch. (2023). Global Skin-Lightening Products Market Forecast.
[3] U.S. Food and Drug Administration. (2022). Regulatory Status of Skin-lightening Agents.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.